COMMAND: Long-term efficacy benefits of risankizumab in ulcerative colitis Presented ByProf. Stefan Schreiber, University Hospital Schleswig-Holstein, Germany TrialPhase 3, COMMAND ConferenceECCO 2024 TypePeer-reviewed article 18 April 2024 13:47